Vascular endothelial growth factor-C (
VEGF-C) has a well-defined action on neoplastic lymphangiogenesis and angiogenesis through
VEGF receptor-3 (VEGFR-3) and
VEGFR-2, respectively, which are generally expressed in endothelial cells. The function of the
VEGF-C/receptors pathway in
tumor cell types is largely unknown. In this study, we examined the expression and role of
VEGF-C/receptors in
gallbladder cancer (GBC) cells. We examined the expression of
VEGF-C in 50 surgical specimens from
gallbladder cancer and three human
gallbladder cancer cell lines. Both
siRNA and
neutralizing antibody to deplete the expression of
VEGF-C were used to characterize the biological effect of
VEGF-C in GBC NOZ cells. Furthermore, we examined the expression of its receptors,
VEGFR-3 and
VEGFR-2, in three human GBC cell lines. Our results are as follows: The expression of
VEGF-C in the invasive marginal portion was significantly higher than the expression in the central portions. All the three GBC cell lines expressed
VEGF-C. Treatment of NOZ cells with
VEGF-C siRNA or a
neutralizing antibody suppressed cell proliferation and invasion. Moreover, all the three GBC cell lines expressed VEGFR3, but only the NOZ cells expressed
VEGFR-2 mRNA. Treatment of NOZ cells with a
VEGFR-3 neutralizing antibody suppressed cell invasion, but treatment of NOZ cells with a
VEGFR-2 neutralizing antibody suppressed cell proliferation and invasion. In conclusion, GBC cells express both
VEGF-C and its receptors.
VEGF-C may have a role in the progressive growth and invasion of human GBC through an autocrine mechanism.